Abstract
To evaluate the efficacy of 3TC (lamivudine), a synthetic nucleoside analogue that inhibits HIV reverse transcriptase in vitro, as treatment for HIV-positive, asymptomatic or mild AIDS-related complex patients. Open-label, multinational and multicentre, non-comparative, escalating dose study. Patients who meet the selection criteria (n = 104) were enrolled in three European countries. Ten to 15 patients were included at each of the six dose levels of 3TC (0.5, 1.0, 2.0, 4.0, 8.0, 12.0 and 20.0 mg/kg daily in two divided doses every 12 h). Virological parameters--immune-complex dissociation (ICD) assay for HIV p24 antigenaemia, plasma HIV RNA load, whole blood assay and cellular viraemia--were evaluated at weeks 0, 4, 12 and 24. Sustained reductions in HIV RNA load and in ICD p24 antigen levels were observed and maintained over the 12-week assessment period. Greater reductions were noted at higher doses but this trend did not reach statistical significance. In 38 patients, reductions of cell viraemia were significantly greater at 4 weeks for patients treated at higher doses of 3TC. These virological data show that 3TC is a potent inhibitor of HIV replication in HIV-positive, asymptomatic or mild ARC patients as assessed by ICD p...Continue Reading
Citations
Dec 3, 2013·Archives of Toxicology·Jia-Long FangJames C Fuscoe
Sep 24, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·R M HoetelmansJ H Beijnen
Dec 12, 2001·HIV Medicine·B G Gazzard
Mar 3, 1999·AIDS Research and Human Retroviruses·A J BrownJ H Condra
Oct 22, 2008·Mutagenesis·Jia-Long FangFrederick A Beland
Feb 12, 1998·Nucleic Acids Research·M HsuM A Wainberg
Jun 23, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jia-Long Fang, Frederick A Beland
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Yudong QuanMark A Wainberg
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
May 22, 2002·Journal of Virology·Koen K A Van RompayThomas W North
Mar 27, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C Loveday
May 26, 2009·Actas dermo-sifiliográficas·M BlanesJ Portilla
Feb 1, 1997·The Journal of Pediatrics·B SölderB H Belohradsky
Feb 12, 1998·Biochemical and Biophysical Research Communications·K KajinoO Hino
Nov 14, 2000·American Journal of Hematology·A Majluf-CruzL Nieto-Cisneros
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·B L RobbinsA Fridland
Mar 1, 1996·Science·M A WainbergV R Prasad